Coronary Syndrome
📧 Sign up to get email alerts when something new happens for Coronary Syndrome.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2025-05-14EMA Authorised: Zyllt (clopidogrel (as hydrogen sulfate)) — Krka, d.d., Novo mesto
EMA authorised Zyllt, a clopidogrel hydrogen sulfate product by Krka, d.d., Novo mesto. It is indicated for preventing vascular events in pa…
-
EMA approval · 2025-05-05EMA Authorised: Clopidogrel / Acetylsalicylic acid Viatris (previously Clopidogrel / Acetylsalicylic acid Mylan) (acetylsalicylic acid;clopidogrel hydrogen sulfate) — Mylan Pharmaceuticals Limited
EMA authorised a fixed-dose combination of clopidogrel and acetylsalicylic acid (Viatris) for acute coronary syndrome and myocardial infarct…
-
FDA approval · 2025-05-05FDA Approved: TICAGRELOR — Original Application (Cipla USA Inc.)
FDA approved Cipla USA Inc.'s original application for ticagrelor, establishing a generic version of the antiplatelet drug. The approval cov…
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: The Effect of IV Cangrelor and Oral Ticagrelor Study [Phase 4]
A Phase 4 trial evaluating the effects of intravenous cangrelor and oral ticagrelor in acute coronary syndrome and its subtypes, completed w…
-
FDA approval · 2025-05-02FDA Approved: TICAGRELOR — Original Application (Alembic Pharmaceuticals Inc.)
FDA approves Alembic Pharmaceuticals' generic ticagrelor (ANDA 208576) under an original application. Ticagrelor is an antiplatelet medicati…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-05-01FDA Approved: TICAGRELOR — Original Application (Apotex Corp.)
FDA approved Apotex's original ANDA for ticagrelor, establishing a generic version of the antiplatelet medication.
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: Mechanisms And Prognosis of Stroke-Heart Syndrome
A clinical trial studying the mechanisms and prognosis of stroke-heart syndrome, currently recruiting, examining how stroke-related cardiac …
-
CLINICAL_TRIALS trial_result · 2025-04-30Clinical Trial Update: Bace1as Role in Heart Failure (BACE1AS-HF)
A completed clinical trial (NCT06213493) investigated the role of BACE1 antisense RNA (BACE1AS) in heart failure, including individuals with…
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: Myocardial Infarction [NA]
A clinical trial sponsored by Aydin Adnan Menderes University investigating acute coronary syndromes related to myocardial infarction has co…
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: Aggressive Smoking Cessation Trial (ASAP) [Phase 3]
Phase 3 clinical trial update for the Aggressive Smoking Cessation Trial (ASAP) is currently recruiting, focusing on patients with acute cor…
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: PASSIvation of Vulnerable Plaque With AZD5718 in AcuTe Coronary syndromE [Phase 2]
A Phase 2 trial evaluating AZD5718 for passivation of vulnerable plaque in acute coronary syndrome has been terminated.
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: Pleiotropic Effects of Dapagliflozin in Patients With Acute Coronary Syndromes [Phase 2, Phase 3]
Clinical trial update describing Phase 2/Phase 3 studies evaluating the pleiotropic effects of dapagliflozin in patients with acute coronary…
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Point of Care Evaluation of High-sensitivity Cardiac Troponin
The University of Edinburgh is conducting a trial evaluating a point-of-care high-sensitivity cardiac troponin test for acute coronary syndr…
-
CLINICAL_TRIALS research · 2025-04-16Clinical Trial Update: International Survey of Acute Coronary Syndromes
An international survey trial on acute coronary syndromes is currently recruiting participants.
-
CLINICAL_TRIALS research · 2025-04-15Clinical Trial Update: MAchine Learning to Boost the Early Diagnosis of Acute Cardiovascular Conditions
A clinical trial update indicates ongoing recruitment for a study using machine learning to improve early diagnosis of acute cardiovascular …
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: Heart Failure-USB: Prediction and Progression
A recruiting clinical trial titled 'Heart Failure-USB: Prediction and Progression' conducted by University Hospital Basel, studying patients…
-
CLINICAL_TRIALS research · 2025-04-08Clinical Trial Update: Platelet Sub-study of the Neomindset Trial [Phase 4]
This document provides an update on the platelet sub-study of the Neomindset Trial (Phase 4) investigating patients with acute coronary synd…
-
CLINICAL_TRIALS research · 2025-04-08Clinical Trial Update: SGLT2 Inhibitor TrEatment iN Patients Awaiting cOronary arTery bYpass Surgery to Reduce Post-opErative AF [Phase 3]
A Phase 3 trial is evaluating whether an SGLT2 inhibitor can reduce postoperative atrial fibrillation in patients with chronic coronary synd…
-
FDA approval · 2025-04-04FDA Approved: TICAGRELOR — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for ticagrelor from Mylan Pharmaceuticals (ANDA 208597), allowing the generic ticagrelor product…
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: Cardiovascular Complications and COVID-19 (CovCardioVasc-Study)
CovCardioVasc-Study, a trial investigating cardiovascular complications in COVID-19, has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: Disparities in the Proportion of Ticagrelor and Prasugrel-eligible Patients with Acute Coronary Syndrome in a Real-world Registry
This real-world registry analysis reports disparities in the proportion of acute coronary syndrome patients eligible for ticagrelor or prasu…
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: Quality of Life Post-ACS in Participants from EMMACE
This document provides a completed update on quality-of-life outcomes in participants with acute coronary syndrome from the EMMACE study.
-
CLINICAL_TRIALS trial_result · 2025-03-26Clinical Trial Update: PRediction of Acute Coronary Syndrome in Acute Ischemic StrokE
This clinical trial update reports results from a completed study assessing prediction of acute coronary syndrome in patients with acute isc…
-
CLINICAL_TRIALS trial_result · 2025-03-26Clinical Trial Update: ALLiance for sEcondary PREvention After an Episode of Acute Coronary Syndrome (ALLEPRE) [NA]
The ALLEPRE trial, studying secondary prevention after an episode of acute coronary syndrome, has completed.
-
FDA approval · 2025-03-25FDA Approved: EPTIFIBATIDE — Supplemental Application (Sagent Pharmaceuticals)
The FDA approved a supplemental application for Eptifibatide from Sagent Pharmaceuticals.